Marisa started the McMaster M.D./Ph.D. program in September 2010. Prior to joining the program, she obtained an Honours B.Sc. in Cellular, Molecular, and Microbial Biology at Thompson Rivers University in May 2010.
Marisa works with Dr. Gerry Wright at the Michael G. DeGroote Institute for Infectious Disease Research where her research aims to discover novel inhibitors of acetyltransferases that pathogens use to inactivate antibiotics.
Aside from science, Marisa enjoys art, philosophy, creative writing, yoga, hiking, and most of all, laughing and spending time with friends. She recently published her own art website.
Art website: http://azadma.wix.com/marisa-azad
Facebook page: https://www.facebook.com/marisa.azad.artwork
Azad, M. A., and Lee, C.Clostridium difficileinfection: a practical approach. 2013.Can. J. CME. 25(2):49-51.
McArthur, A. G., Waglechner, N., Nizam, F., Yan, A., Azad, M. A.,et al.2013. The comprehensive antibiotic resistance database. AAC. 57(7):3348-3357.
Azad, M. A. and Wright, D. G. 2012. Determining the mode of action of bioactive compounds. J. Bioorg. Med. Chem. 20(6):1929-1939.
- Azad, M. A. and Wright, D. G. 2011. Determining the mode of action of bioactive compounds. J. Bioorg. Med. Chem. Accepted.
- Azad, M. A., Huttunen-Hennelly, H. E. K., and Friedman, C. R. 2011. Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides. Antimicrob. Agents Chemother. 55:2137-2145.
- Azad, M. A. and Huttunen-Hennelly, H. E. K. (2010 Provisional Patent: Canada). MAW-1 as a novel α-helical antimicrobial peptide with an N-terminal glycine "cap."